Coya Therapeutics, Inc. (COYA)
NASDAQ·Healthcare·Biotechnology
$5.06
+4.77%
Mkt Cap $80.42M
Analyst Ratings
No recent rating data.
Price Target (2 analysts)
$17.50
Range $17.00 – $18.00
Implied Upside
+245.8%
Consensus $17.50 vs current $5.06
NASDAQ·Healthcare·Biotechnology
$5.06
+4.77%
Mkt Cap $80.42M
No recent rating data.
Price Target (2 analysts)
$17.50
Range $17.00 – $18.00
+245.8%
Consensus $17.50 vs current $5.06